BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38258554)

  • 21. [Transcription factor EB related autophagy in the treatment of multiple myeloma and its mechanism].
    Zhang ZH; Zhang RJ; Han N; Li C; Wang LL; Xing EH; Gu CH; Hao CL
    Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):407-414. PubMed ID: 34218584
    [No Abstract]   [Full Text] [Related]  

  • 22. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.
    Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG
    Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xie-Bai-San increases NSCLC cells sensitivity to gefitinib by inhibiting Beclin-1 mediated autophagosome formation.
    Ma C; Zhang X; Mo X; Yu Y; Xiao Z; Wu J; Ding L; Lei C; Zhu Y; Zhang H
    Phytomedicine; 2024 Mar; 125():155351. PubMed ID: 38232540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycin.
    Zemp FJ; Lun X; McKenzie BA; Zhou H; Maxwell L; Sun B; Kelly JJ; Stechishin O; Luchman A; Weiss S; Cairncross JG; Hamilton MG; Rabinovich BA; Rahman MM; Mohamed MR; Smallwood S; Senger DL; Bell J; McFadden G; Forsyth PA
    Neuro Oncol; 2013 Jul; 15(7):904-20. PubMed ID: 23585629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene.
    Urbasic AS; Hynes S; Somrak A; Contakos S; Rahman MM; Liu J; MacNeill AL
    Am J Vet Res; 2012 Aug; 73(8):1252-61. PubMed ID: 22849686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.
    Kellish P; Shabashvili D; Rahman MM; Nawab A; Guijarro MV; Zhang M; Cao C; Moussatche N; Boyle T; Antonia S; Reinhard M; Hartzell C; Jantz M; Mehta HJ; McFadden G; Kaye FJ; Zajac-Kaye M
    J Clin Invest; 2019 Apr; 129(6):2279-2292. PubMed ID: 31033480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR).
    Willenbacher W; Thangavadivel S; Greil R; Willenbacher E; Weger R; Manzl C; Jöhrer K; Brunner A
    Leuk Lymphoma; 2016 Oct; 57(10):2330-41. PubMed ID: 26880040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of Myxoma virus gateway entry and expression libraries and validation of viral protein expression.
    Smallwood SE; Rahman MM; Werden SJ; Martino MF; McFadden G
    Curr Protoc Microbiol; 2011 May; Chapter 14():Unit 14A.2. PubMed ID: 21538302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myxoma virus oncolytic efficiency can be enhanced through chemical or genetic disruption of the actin cytoskeleton.
    Irwin CR; Favis NA; Agopsowicz KC; Hitt MM; Evans DH
    PLoS One; 2013; 8(12):e84134. PubMed ID: 24391902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in viral oncolytics for treatment of multiple myeloma - a focused review.
    Sarwar A; Hashim L; Faisal MS; Haider MZ; Ahmed Z; Ahmed TF; Shahzad M; Ansar I; Ali S; Aslam MM; Anwer F
    Expert Rev Hematol; 2021 Dec; 14(12):1071-1083. PubMed ID: 34428997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation.
    Tucci M; Stucci S; Savonarola A; Resta L; Cives M; Rossi R; Silvestris F
    Exp Hematol; 2014 Oct; 42(10):897-908.e1. PubMed ID: 24971696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reovirus as a viable therapeutic option for the treatment of multiple myeloma.
    Thirukkumaran CM; Shi ZQ; Luider J; Kopciuk K; Gao H; Bahlis N; Neri P; Pho M; Stewart D; Mansoor A; Morris DG
    Clin Cancer Res; 2012 Sep; 18(18):4962-72. PubMed ID: 22761466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β.
    Naik S; Nace R; Barber GN; Russell SJ
    Cancer Gene Ther; 2012 Jul; 19(7):443-50. PubMed ID: 22522623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic signatures associated with oncolytic myxoma viral infections.
    Mahar R; Ragavan M; Chang MC; Hardiman S; Moussatche N; Behar A; Renne R; Merritt ME
    Sci Rep; 2022 Jul; 12(1):12599. PubMed ID: 35871072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of autophagy promotes cisplatin-induced apoptotic cell death through Atg5 and Beclin 1 in A549 human lung cancer cells.
    Chen J; Zhang L; Zhou H; Wang W; Luo Y; Yang H; Yi H
    Mol Med Rep; 2018 May; 17(5):6859-6865. PubMed ID: 29512762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ClC5 Decreases the Sensitivity of Multiple Myeloma Cells to Bortezomib via Promoting Prosurvival Autophagy.
    Zhang H; Pang Y; Ma C; Li J; Wang H; Shao Z
    Oncol Res; 2018 Apr; 26(3):421-429. PubMed ID: 28899456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-MA Enhanced Chemosensitivity in Cisplatin Resistant Hypopharyngeal Squamous Carcinoma Cells via Inhibiting Beclin -1 Mediated Autophagy.
    Zhang J; Mao W; Liu Y; Ding J; Wang J; Yu Z; Huang R; Yang S; Sun Y; Dong P
    Curr Pharm Des; 2021; 27(7):996-1005. PubMed ID: 33349212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic changes in Beclin-1, LC3B and p62 at various time points in mice with temporary middle cerebral artery occlusion and reperfusion (tMCAO).
    Deng M; Zhong X; Gao Z; Jiang W; Peng L; Cao Y; Zhou Z; Huang L
    Brain Res Bull; 2021 Aug; 173():124-131. PubMed ID: 33974897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acupuncture regulates autophagy in hippocampal neurons of cerebral ischemia/reperfusion injured rats by activating type Ⅲ PI3K/Beclin-1 pathway].
    Tang H; Lü QY; Wang HJ; Jiang SS; Chen CT; Tian HM; Xiang J; Li YP
    Zhen Ci Yan Jiu; 2023 May; 48(5):423-30. PubMed ID: 37247854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA MALAT-1 Elevates HMGB1 to Promote Autophagy Resulting in Inhibition of Tumor Cell Apoptosis in Multiple Myeloma.
    Gao D; Lv AE; Li HP; Han DH; Zhang YP
    J Cell Biochem; 2017 Oct; 118(10):3341-3348. PubMed ID: 28295550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.